Herein, we measured the PUMA expression in two both HT29 and HCT116 lines after AKT knockdown to demonstrated that the inhibition of SLPI repressed the AKT pathway to promotes PUMA expression in CRC (Fig. 6A). The gene discussed is SLPI; the disease is colorectal carcinoma.